Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Pharmaceutical Preparations.
The next scheduled catalyst is Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2 on November 15, 2028. There is 1 upcoming event on record.
Cash runway is approximately 0 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.
| Date | Event | Type | Phase |
|---|---|---|---|
| November 15, 2028 | Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2 | Trial Milestone | Phase 3 |
Track SMNR alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open SMNR in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| July 7, 2026 | 8-K filed: Material agreement, Reg FD disclosure | Corporate | — |
| March 17, 2026 | 8-K filed: Leadership change | Corporate | — |
| December 3, 2025 | 8-K filed: Other event | Filing | — |
| September 26, 2025 | 8-K filed: Material agreement, Acquisition completed, Leadership change, Reg FD disclosure, Other event | Corporate | — |
| August 22, 2025 | 8-K filed: Material agreement | Corporate | — |
| August 11, 2025 | 8-K filed: Other event | Filing | — |
| July 28, 2025 | 8-K filed: Material agreement | Corporate | — |
| July 11, 2025 | 8-K filed: Other event | Filing | — |
| June 12, 2025 | 8-K filed: Other event | Filing | — |
| May 12, 2025 | 8-K filed: Other event | Filing | — |
| April 22, 2025 | 8-K filed: Material agreement | Corporate | — |
| April 16, 2025 | 8-K filed: Other event | Filing | — |
| March 15, 2019 | A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 | Trial Milestone | Phase 2 |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.